Cytokine balance in the lungs of patients with acute respiratory distress syndrome

被引:421
作者
Park, WY
Goodman, RB
Steinberg, KP
Ruzinski, JT
Radella, F
Park, DR
Pugin, J
Skerrett, SJ
Hudson, LD
Martin, TR
机构
[1] VA Puget Sound Hlth Care Syst, Harborview Med Ctr, Sect Pulm Crit Care Med, Med Res Serv, Seattle, WA USA
[2] Univ Washington, Sch Med, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA
[3] Univ Geneva, Med Ctr, Dept Med Intens Care, CH-1211 Geneva, Switzerland
关键词
acute respiratory distress syndrome; cytokine receptors; cytokines; IL-1; TNF;
D O I
10.1164/ajrccm.164.10.2104013
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Acute respiratory distress syndrome (ARDS) involves an Intense Inflammatory response in the lungs, with accumulation of both pro- and antiinflammatory cytokines in bronchoalveolar lavage fluid (BALF). Our goal was to determine how the balance between pro- and antiinflammatory mediators in the lungs changes before and after the onset of ARDS. We identified 23 patients at risk for ARDS and 46 with established ARDS and performed serial bronchoalveolar lavage (BAL). We used immunoassays to measure tumor necrosis factor alpha (TNF-alpha) and soluble TNF-alpha receptors I and II; interleukin 1 beta (IL-1 beta), IL-1 beta receptor antagonist, and soluble IL-1 receptor II; IL-6 and soluble IL-6 receptor; and IL-10. We used sensitive bioassays to measure net TNF-alpha, IL-1 beta and IL-6 activity. Although individual cytokines increased before and after onset of ARDS, greater increases occurred in cognate receptors and/or antagonists, so that molar ratios of agonists/antagonists declined dramatically at the onset of ARDS. The molar ratios remained low for 7 d or longer, limiting the activity of soluble IL-1 beta and TNF-alpha in the lungs at the onset of ARDS. This significant antiinflammatory response early in ARDS may provide a key mechanism for limiting the net inflammatory response in the lungs.
引用
收藏
页码:1896 / 1903
页数:8
相关论文
共 47 条
[1]  
Aarden L, 1985, LYMPHOKINES, V10, P175
[2]   CEREBROSPINAL-FLUID INTERLEUKIN-1-BETA INTERLEUKIN-1 RECEPTOR ANTAGONIST BALANCE AND TUMOR-NECROSIS-FACTOR-ALPHA CONCENTRATIONS IN TUBERCULOUS, VIRAL AND ACUTE BACTERIAL-MENINGITIS [J].
AKALIN, H ;
AKDIS, AC ;
MISTIK, R ;
HELVACI, S ;
KILICTURGAY, K .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1994, 26 (06) :667-674
[3]  
ANDUS T, 1997, GUT, V41, P650
[4]  
AREND WP, 1989, J IMMUNOL, V143, P1851
[5]   Increased expression of functionally active membrane-associated tumor necrosis factor in acute respiratory distress syndrome [J].
Armstrong, L ;
Thickett, DR ;
Christie, SJ ;
Kendall, H ;
Millar, AB .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2000, 22 (01) :68-74
[6]   Relative production of tumour necrosis factor a and interleukin 10 in adult respiratory distress syndrome [J].
Armstrong, L ;
Millar, AB .
THORAX, 1997, 52 (05) :442-446
[7]   REPORT OF THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ACUTE RESPIRATORY-DISTRESS SYNDROME - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
Cochin, B ;
Lanken, PN ;
Leeper, KV ;
Marini, J ;
Murray, JF ;
Oppenheimer, L ;
Pesenti, A ;
Reid, L ;
Rinaldo, J ;
Villar, J ;
van Asbeck, BS ;
Dhainaut, JF ;
Mancebo, J ;
Matthay, M ;
Meyrick, B ;
Payen, D ;
Perret, C ;
Fowler, AA ;
Schaller, MD ;
Hudson, LD ;
Hyers, T ;
Knaus, W ;
Matthay, R ;
Pinsky, M ;
Bone, RC ;
Bosken, C ;
Johanson, WG ;
Lewandowski, K ;
Repine, J ;
Rodriguez-Roisin, R ;
Roussos, C ;
Antonelli, MA ;
Beloucif, S ;
Bihari, D ;
Burchardi, H ;
LeMaire, F ;
Montravers, P ;
Petty, TL ;
Robotham, J ;
Zapol, W .
JOURNAL OF CRITICAL CARE, 1994, 9 (01) :72-81
[8]   MACROPHAGE DEACTIVATION BY INTERLEUKIN-10 [J].
BOGDAN, C ;
VODOVOTZ, Y ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1549-1555
[9]   THE INHIBITORY ACTIVITY OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IS ENHANCED BY TYPE-II INTERLEUKIN-1 SOLUBLE RECEPTOR AND HINDERED BY TYPE-I INTERLEUKIN-1 SOLUBLE RECEPTOR [J].
BURGER, D ;
CHICHEPORTICHE, R ;
GIRI, JG ;
DAYER, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :38-41
[10]  
CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434